Kymera Therapeutics Inc

KYMRStocksBiotechnologyUnited StatesNasdaqUSD

Price

$105.94

Today

-3.5%

YTD

+36.4%

About

Kymera Therapeutics Inc is a biotech company focused on advancing the field of targeted protein degradation. Operating globally, it leverages cellular machinery to eliminate disease-causing proteins. Working in the biotech sector, Kymera Therapeutics Inc seeks to expand drug development and discovery. It aspires to propel the treatment landscape by developing novel, small-molecule therapeutics. The company works to improve modern medicine through its proprietary Pegasus drug discovery platform. Monitor the KYMR share price by adding it to your eToro watchlist.

Price chart

Closing price history for KYMR (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-33.88

P/S (TTM)102.71

P/B (TTM)6.03

Market cap$9.13B

Cap tierMid-cap

Industry avg P/E-1.91

Profitability

Gross margin92.16%

EBIT margin-329.83%

Net margin-94.17%

ROE-24.15%

ROA-21.58%

Earnings & Revenue

Revenue (TTM)$105.00M

Revenue growth (1Y)+134.8%

EPS (TTM)-$3.24

Free cash flow$-237.96M

Total debt$78.56M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)1.56

Employees238

Next earnings3 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.